Cerus (CERS) Total Non-Current Liabilities (2010 - 2026)
Cerus' (CERS) quarterly Total Non-Current Liabilities came in at $129.3 million in Q2 2026, down 15.26% year-over-year from $152.5 million in Q2 2025, and down 13.37% quarter-over-quarter from $149.2 million in Q1 2026.
Analysis
Cerus (CERS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cerus has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $129.3 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 15.26% year-over-year to $129.3 million; the TTM figure through Jun 2026 stood at $129.3 million (down 15.26% YoY), while the FY2025 annual figure was $151.5 million, up 8.11% from the prior year.
- Total Non-Current Liabilities came in at $129.3 million for Q2 2026 at Cerus, down from $149.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $154.0 million in Q3 2023 to a low of $129.3 million in Q2 2026.
- Average Total Non-Current Liabilities over 5 years is $142.3 million, with a median of $142.7 million recorded in 2023.
- Year-over-year, Total Non-Current Liabilities gained 15.92% in 2025 and slipped 15.26% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $146.0 million in 2022, then retreated by 3.4% to $141.1 million in 2023, then dropped by 0.66% to $140.1 million in 2024, then increased by 8.11% to $151.5 million in 2025, then dropped by 14.68% to $129.3 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $129.3 million in Q2 2026, $149.2 million in Q1 2026, and $151.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Cerus | 521.95 Mn | 466.38 Mn | 29.53 Mn | 129.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.25 Mn |
| Mar 31, 2026 | 149.20 Mn |
| Dec 31, 2025 | 151.50 Mn |
| Sep 30, 2025 | 147.76 Mn |
| Jun 30, 2025 | 152.53 Mn |
| Mar 31, 2025 | 146.51 Mn |
| Dec 31, 2024 | 140.13 Mn |
| Sep 30, 2024 | 131.46 Mn |
| Jun 30, 2024 | 131.58 Mn |
| Mar 31, 2024 | 135.54 Mn |
| Dec 31, 2023 | 141.07 Mn |
| Sep 30, 2023 | 153.99 Mn |
| Jun 30, 2023 | 144.37 Mn |
| Mar 31, 2023 | 147.36 Mn |
| Dec 31, 2022 | 146.03 Mn |
| Sep 30, 2022 | 138.08 Mn |
| Jun 30, 2022 | 136.57 Mn |
| Mar 31, 2022 | 138.22 Mn |
| Dec 31, 2021 | 149.54 Mn |
| Sep 30, 2021 | 135.47 Mn |